Management of neurologic disorders of the larynx

Annals of Otology, Rhinology and Laryngology

Volumn 117, Issue 5, 2008, Pages 317-326

  Woodson, Gayle ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Larynx; Neurologic disorder

Indexed keywords

ACOUSTICS; AMYOTROPHIC LATERAL SCLEROSIS; BREATHING; CEREBELLUM INJURY; CINERADIOGRAPHY; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSTONIA; ELECTROMYOGRAPHY; ESSENTIAL TREMOR; HUMAN; LARYNGOSCOPY; LARYNX DISORDER; MOUTH CAVITY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PARKINSON DISEASE; PARKINSONISM; PHONATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SPEECH; STROKE; SWALLOWING; LARYNX; METHODOLOGY; OTORHINOLARYNGOLOGY; PATHOPHYSIOLOGY;

ELECTROMYOGRAPHY; HUMANS; LARYNGEAL DISEASES; LARYNGOSCOPY; LARYNX; NERVOUS SYSTEM DISEASES; OTOLARYNGOLOGY; PHYSICAL EXAMINATION;

EID: 45949098291     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940811700501     Document Type: Review

References (38)

1. Hughes RG, Gibbin KP, Lowe J. Vocal fold abductor paralysis as a solitary and fatal manifestation of multiple system atrophy. J Laryngol Otol 1998;112:177-8.
2. Qureshi AI, Choundry MA, Mohammad Y, et al. Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit 2004;10:CR684-C689.
3. Aronson AE. Clinical voice disorders. New York, NY: Thieme, 1985:71.
4. Miller RH, Woodson GE. Neurologic evaluation of the larynx and pharynx. In: Johnson J, Blitzer A, Ossoff R, Thomas J, eds. Instruction courses, American Academy of Otolaryngology. Vol 3. St Louis, Mo: Mosby-Year Book, 1990:39-44.
5. Woodson GE, Zwirner P, Murry T, Swenson M. Use of flexible laryngoscopy to classify patients with spasmodic dysphonia. J Voice 1991;5:85.
6. Zwirner P, Murry T, Woodson GE. Phonatory function of neurologically impaired patients. J Commun Disord 1991;24:287-300.
7. Sapienza CM, Walton S, Murry T. Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading. J Voice 2000;14:502-20.
8. Sataloff RT, Mandel S, Mann EA, Ludlow CL; AAEM Laryngeal Task Force. Laryngeal electromyography: an evidence-based review. Muscle Nerve 2003;28:767-72.
9. Hillel AD. The study of laryngeal muscle activity in normal human subjects and in patients with laryngeal dystonia using multiple fine-wire electromyography. Laryngoscope 2001;111(suppl 97):1-47.
10. Woodson GE. Respiratory activity of the cricothyroid muscle in conscious humans. Laryngoscope 1990;100:49-53.
11. Woodson G, Hochstetler H, Murry T. Botulinum toxin therapy for abductor spasmodic dysphonia. J Voice 2006;20:137-43.
12. Yin SS, Qiu WW, Stucker FJ. Major patterns of laryngeal electromyography and their clinical application. Laryngoscope 1997;107:126-36.
13. Crumley RL. Laryngeal synkinesis revisited. Ann Otol Rhinol Laryngol 2000;109:365-71.
14. Kuna ST, Insalaco G, Woodson GE. Thyroarytenoid muscle activity during wakefulness and sleep in normal adults. J Appl Physiol 1988;65:1332-9.
15. Hirano M, Nozoe I, Shin T, Maeyama M. Electromyography for laryngeal paralysis. In: Hirano M, Kirchner J, Bless D, eds. Neurolaryngology: recent advances. Boston, Mass: College-Hill, 1987:232-48.
16. Woodson GE. Spontaneous laryngeal reinnervation after recurrent laryngeal or vagus nerve injury. Ann Otol Rhinol Laryngol 2007;116:57-65.
17. Blitzer A, Jahn AF, Keidar A. Semon's law revisited: an electromyographic analysis of laryngeal synkinesis. Ann Otol Rhinol Laryngol 1996;105:764-9.
18. Stachler RJ, Hamlet SL, Choi J, Fleming S. Scintigraphic quantification of aspiration reduction with the Passy-Muir valve. Laryngoscope 1996;106:231-4.
19. Aviv JE, Murry T, Zschommler A, Cohen M, Gartner C. Flexible endoscopic evaluation of swallowing with sensory testing: patient characteristics and analysis of safety in 1,340 consecutive examinations. Ann Otol Rhinol Laryngol 2005;114:173-6.
20. Shill H, Stacy M. Respiratory function in Parkinson's disease. Clin Neurosci 1998;5:131-5.
21. Lim YS, Kennedy NJ. Multiple system atrophy as a cause of upper airway obstruction. Anesthesia 2007;62:1179-82.
22. Guindi GM, Michaels L, Bannister R, Gibson W. Pathology of the intrinsic muscles of the larynx. Clin Otolaryngol Allied Sci 1981;6:101-9.
23. Ramig LO, Countryman S, Thompson LL, Horii Y. Comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hear Res 1995;38:1232-51.
24. Hill AN, Jankovic J, Vuong KD, Donovan D. Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism. Mov Disord 2003;18:1190-2.
25. Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 2004;62:37-40.
26. Pahwa R, Lyons KE. Essential tremor: differential diagnosis and current therapy. Am J Med 2003;115:134-42.
27. Thanvi B, Lo N, Robinson T. Essential tremor - the most common movement disorder in older people. Age Ageing 2006;35:344-9.
28. Adler CH, Bansberg SF, Hentz JG, et al. Botulinum toxin type A for treating voice tremor. Arch Neurol 2004;61:1416-20.
29. Woodson G. Cricopharyngeal myotomy and arytenoid adduction in the management of combined laryngeal and pharyngeal paralysis. Otolaryngol Head Neck Surg 1997;116:339-43.
30. Mao VH, Abaza M, Spiegel JR, et al. Laryngeal myasthenia gravis: report of 40 cases. J Voice 2001;15:122-30.
31. Ramig LO, Scherer RC, Klasner ER, Titze IR, Horii Y. Acoustic analysis of voice in amyotrophic lateral sclerosis: a longitudinal case study. J Speech Hear Disord 1991;55:2-14.
32. Howell K, Selber P, Graham HK, Reddihough D. Botulinum neurotoxin A: an unusual systemic effect. J Paediatr Child Health 2007;43:499-501.
33. Papapetropoulos S, Singer C. Botulinum toxin in movement disorders. Semin Neurol 2007;27:183-94.
34. Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 1976;85:451-9.
35. Netterville JL, Stone RE, Rainey C, Zealear DL, Ossoff RH. Recurrent laryngeal nerve avulsion for treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 1991;100:10-4.
36. Miller RH, Woodson GE, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. Arch Otolaryngol Head Neck Surg 1987;113:603-5.
37. Blitzer A, Brin MF, Fahn S, Lovelace RE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 1988;98:193-7.
38. Chhetri DK, Mendelsohn AH, Blumin JH, Berke GS. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia. Laryngoscope 2006;116:635-42.